Women’s Health Market

Women’s Health Market Size, Share, Growth Analysis, By Application Outlook(Postmenopausal Osteoporosis, Hormonal Infertility), By Age Outlook(50 years and above, Postmenopausal Osteoporosis), By Region(North America, Europe) - Industry Forecast 2024-2031


Report ID: UCMIG35I2319 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Women’s Health Market Insights

Market Overview:

In 2022, the global women's health market had a total worth of USD 41.35 billion, and it is anticipated to experience a 5.4% compound annual growth rate (CAGR) from 2023 to 2030. This growth is primarily driven by an increase in the elderly female population and the introduction of new women's health products like Relugoliz and Orilissa. Additionally, government-backed initiatives aimed at enhancing women's health and raising awareness are expected to fuel market expansion in the forecasted period. However, the market saw a slower growth rate than expected during the pandemic due to reduced access to contraception and gynecological testing, leading to a rise in unsafe abortions and unwanted pregnancies, especially in developing nations.

Women’s Health Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Pharmaceuticals by segment aggregation, the contribution of the Pharmaceuticals in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Women’s Health was estimated to be valued at US$ XX Mn in 2021.

The Women’s Health Market is estimated to grow at a CAGR of XX% by 2028.

The Women’s Health Market is segmented on the basis of Application Outlook, Age Outlook, Region.

Based on region, the Women’s Health Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Women’s Health Market are , AbbVie, Inc. , Bayer AG , Merck & Co., Inc. , Pfizer, Inc. , Teva Pharmaceutical Industries Ltd. , Agile Therapeutics , Amgen, Inc. , Apothecus Pharmaceutical Corp. , Blairex Laboratories, Inc. , Ferring B.V..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Women’s Health Market

Product ID: UCMIG35I2319

$5,300
BUY NOW GET FREE SAMPLE